Dasman Diabetes Institute marks 100 years of insulin

Dasman Diabetes Institute marks 100 years of insulin

KUWAIT: In celebration of the 100th anniversary of insulin, Dasman Diabetes Institute (DDI), a research institute established by the Kuwait Foundation for the Advancement of Sciences, held a series of talks and facilitated roundtable discussions with health ministry stakeholders across primary and secondary care, as well as the pharmaceutical sector and patient advocates, supported by Novo Nordisk. This was the first time in Kuwait that prominent stakeholders in diabetes care met to discuss the possible options to improve diabetes management in Kuwait.

The event was opened by Dr Qais Al-Duwairi, Director-General of DDI, followed by Ole Moesby, the Ambassador of Denmark, who highlighted the global diabetes burden. Dr Akin Aksekili, Novo Nordisk Vice-President, also gave a speech to commemorate the 100 years of diabetes care innovation and establish hope for the next generation of diabetes treatments and health solutions.

Dr Dalal Al-Hajeri, representing the primary healthcare sector in Kuwait, discussed the unmet needs in diabetes care and highlighted areas of focus and strengths in primary care. Dr Peter Kurtzhals, Chief Scientific Advisor of Novo Nordisk, presented an insightful look into the future of diabetes management by detailing the innovations in insulin therapy we can look forward to seeing.

The roundtable discussion was moderated